Planet Toccer Holding Ltd., founded by former world class athlete, Mark Thomas, has teamed up with leading animated film and gaming industry veterans to launch Goaly Moley, the first 3D mobile game app from the Space Sports franchise.
Space Sports’ Goaly Moley is a highly engaging and competitive 3D game app with rich graphics and cosmic monsters. Players can test their soccer skills against Galactic Moles as they score points against Madu the Monster. Space Sports is holding the first Goaly Moley Championship of the ZaZa Galaxy starting on April 15th, 2013. The winner will receive an all expenses paid trip for two to London to attend the U.E.F.A. (Union of European Football Association) Champions League Final on May 25th, 2013.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60223-planet-toccer-launches-free-space-sports-app-3d-mobile-games-platform
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
Well, this certainly break's my 1 song per month rule. I can't help it. Halloween's got me by the Candy Apples. Normally, I create the music first and then I make a video for it later but I didn't want to go through my video madness routine at the very end and so I did a little bit of this and a little bit of that and got it all wrapped up together at the same time. I didn't have the opportunity to take the song out for a test drive as I always take a cruise with my bro and we listen to it in his car and then later I make some adjustments at home. It sound's fine to me through my laptop and the video look's okay and so I'm just gonna upload it as is.
Elon Musk unveils the Model 3 at the Tesla Design Studio March 31, 2016. I was among the first to take a ride in the new car and was impressed with the design, power, and great looks! The interior just has one 4:3 ratio monitor in a horizontal positon. There are no gauges or dials anywhere! Still a very fast car and I'm sure options will include models that can go 0-60 in the 4.5 second range. Base models will innclude auto pilot and supercharging.
Read about a $3,000,000 mobile home in escrow at http://www.themaliburealestateblog.com
Her wedding day turned into a nightmare. She followed Gary to a remote and dangerous monastery. But what they find there will test their bond and their fate. From #1 NY Times bestselling author Christine Feehan comes a tale of vampire hunters, adventure and romance. http://www.ChristineFeehan.com Paranormal Romance
Subaru of America, Inc. today announced the completion of a Pet Travel Seat Pilot Study as part of its continued partnership with Center for Pet Safety (CPS), a registered 501(c)(3) non-profit research and consumer advocacy organization. Subaru and CPS have tested pet products most commonly used by pet parents when traveling. Phase one tested pet harnesses, phase two tested pet crates and carriers, and now, phase three has tested pet travel seats.
A pet travel seat is typically used in a vehicle to hold or elevate the pet, but does not offer full containment. The Pet Travel Seat Pilot Study found that while a pet travel seat may offer distraction prevention, it will likely not offer crash protection in the event of an accident, which could lead to injury of the pet and the human vehicle passengers. The quality of commonly available pet travel seats did not provide effective protection in a crash scenario.
Based on the scientific test evidence collected over the past four years, in part through its partnership with Subaru, CPS can now identify the safest travel options for most pets. For small dogs and cats, Center for Pet Safety recommends one of the 2015 Top Performing Carriers; for medium and large dogs either the 2015 Top Performing Crate - Gunner Kennels G1 Intermediate with 8' Tie Down Straps, or a Center for Pet Safety Certified Harness. To view top performing products and CPS Certified products, visit www.CenterforPetSafety.org.
To view the multimedia release go to:
http://www.multivu.com/players/English/7074158-subaru-cps-pet-travel-seat-study/
Layered meringue cookies, aromatic flavors and bold colors and patterns are just a taste of what’s to come in the food and dessert world this year. The Wilton Test Kitchen and Decorating Room named the Top 10 trends in baking and decorating.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7420651-wilton-baking-decorating-trends/
Phenogen Sciences, Inc. [www.phenogensciences.com] today announced the immediate availability of BREVAGen™, a predictive risk test for the millions of women at above average risk of developing estrogen-receptor positive breast cancer. This first-in-class, scientifically-validated risk assessment test examines a woman’s clinical risk factors, such as her lifetime exposure to estrogen, combined with scientifically validated genetic markers to determine each patient’s personalized five-year and lifetime risk of developing breast cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58399-phenogen-sciences-brevagen-breast-cancer-risk-assessment-test-availability
Abbott and the United States Department of Defense today announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs). As part of a multi–phased approach, the tests would be developed for Abbott’s i–STAT® System, a handheld, diagnostic analyzer that is currently used for other point-of-care testing, including among military service members. Concussions are a significant health concern for military service members.1 With the development of new tests, physicians could use the information to positively impact the care of people with a suspected concussion.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7293951-abbott-u-s-department-of-defense-develop-portable-blood-tests-concussions/
Tektronix, Inc., a leading worldwide provider of test, measurement and monitoring instrumentation, has introduced a new class of affordable spectrum analyzers based on a USB architecture with a list price of just $3,490. The new RSA306 sets a new price/performance threshold for spectrum analyzers and features a broad 9 kHz to 6.2 GHz frequency range, 40 MHz real time bandwidth and weighs in at just 1.2 pounds. When used with Tektronix SignalVu-PC software, it offers advanced analysis capabilities for such applications as budget-conscious research and development, mobile radio network installation, interference hunting and university level lab classes.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7074356-tektronix-announces-affordable-full-featured-portable-spectrum-analyzer/
NI (Nasdaq: NATI) today announced VirtualBench, an all-in-one instrument that integrates a mixed-signal oscilloscope, function generator, digital multimeter, programmable DC power supply and digital I/O. Users interact with VirtualBench through software applications that run on PCs or iPads. The device provides the most common functionality affordably and opens up new possibilities for how engineers can use benchtop instruments.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7230751-ni-reshapes-instrumentation-with-software-based-device-virtualbench
